close read more

Servier - Independent international pharmaceutical laboratory

The Servier Group

Committed to therapeutic progress to serve patient needs

Meet the healthcare challenges of tomorrow

Committed employees

Men and women proud to contribute to care for patients and save lives

Join our Group

Servier R&D

Meeting patient needs as effectively as possible

Accelerate therapeutic innovation

A local production

The agility of an integrated industrial model

Industrial excellence for a quality healthcare offering

Our news


New ways of working

logo twitter


> 150
countries in which
the Group’s medicines
are distributed
> 20 %

of brand-name revenue
invested in R&D every year

4.7 billion

euros in revenue in 2020/2021 comprising €3.3 billion for brand-name medicines and €1.4 billion for generic medicines.

4 therapeutic areas

cardiometabolism, neuroscience
and immuno-inflammation

Join our teams!

We do everything possible for all Group employees to have the means to succeed, to adapt, to take on responsibilities and to grow. At Servier, you will be offered a unique and meaningful professional experience.

Understanding Sjögren’s syndrome, an autoimmune disease

Sjögren’s syndrome is the second most common autoimmune disease after rheumatoid arthritis.


My Health Partner delivers personalized content for patients with hypertension, coronary artery disease, high cholesterol, or diabetes.

The basis for our actions

Because passing on to future generations a world that can ensure access to quality health care for all is our vision for the future, at Servier, all over the world, we are ready to meet the health care challenges of tomorrow, for and with patients. Discover our corporate video.